![Mark Shearman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Shearman
Directeur Général chez
Aprinoia Therapeutics, Inc. /US/
Profil
Mark S.
Shearman is currently the Chief Executive Officer & Director at Aprinoia Therapeutics, Inc. He previously held positions as the Executive Director-Neuroscience at Merck & Co., Inc., the Executive Director at Merck Research Laboratories Massachusetts LLC, and the Senior Director-Cellular & Molecular Neuroscience at Merck Sharp & Dohme Research Laboratories Neuroscience Research.
He also served as the Senior VP-Research & Early Development at Merck KGaA and the Chief Scientific Officer & Vice President at Beacon Therapeutics (USA), Inc. Dr. Shearman's most recent former position was as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. He received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.
Postes actifs de Mark Shearman
| Sociétés | Poste | Début |
|---|---|---|
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Directeur Général | 14/07/2023 |
Anciens postes connus de Mark Shearman
| Sociétés | Poste | Fin |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Directeur Technique/Scientifique/R&D | 20/04/2021 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2015 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Directeur/Membre du Conseil | 01/07/2009 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2009 |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | Corporate Officer/Principal | 01/01/2005 |
Formation de Mark Shearman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Health Technology |
Choisissez Zonebourse 
